APP is also a substrate of AEP, and in mouse models of AD, deletion or inhibition of AEP normalizes synaptic function, improves cognitive function, and lessens Aβ and tau content and amyloid plaque accumulation (Zhang et al., 2015; Qian et al., 2024). Here, MAPT is linked to Alzheimer disease.